Bookmark and Share

Last Minute:          For more news, click here.

Authentication
       
       
Remember me? 


PS: The quotes after 2011-04-08 are still temporary and may have for that reason the Open values wrong until furter updates...
Change to GENZYME CORPORATI Static Chart

Without price
GENZYME CORPORATI - [Ticker: GENZ]Chart GENZYME CORPORATI  News GENZYME CORPORATI  Download Historical Prices for Metastock GENZYME CORPORATI and Others  Technical Analysis GENZYME CORPORATI  
Last Trade0.00Last Trade Time - 00:00:00
VariationN/A (N/A)Open0.00
High0.00Low0.00
Volume0Average Volume (3m)0
YieldBid / AskN/A
Former Close0.0052 Week Range[0.00 - 0.00]
PER0.00%EPS0.00
Ex-Dividend DateDividend Payment
Market Capitalization0 1 Year Price-Target0.00
Note: The data may have some minutes of delay.

 News about GENZYME CORPORATI [GENZ]:   (ordered by relevance)
Metastatic Breast Cancer Patients Benefit from Targeted Therapies Matched to Genomic Alterations  OncoZine ImmunoGen Appoints Tracey L. McCain, Esq. to Its Board of Directors  Business Wire Cancer Nanomedicine Market Dynamics Analysis, Production, Supply and Demand, Covered in the Latest Research 2021-2028  Digital Journal Viscosupplementation Market Size 2021, Share Estimation, Trend Analysis, Industry Growth Rate, Company Profiles with Strategies, Global Sales and Revenues, Future Demands, Production-Scenario and Supply Forecast 2026  Taiwan News Movers & Shakers, July 9 | BioSpace  BioSpace Global Clinical In Vitro Diagnostic Medical Laboratory Services Markets Report 2021-2025: Focus on Chemistry, Hematology, Microbiology, Pathology, Covid-19, and Molecular Dx - ResearchAndMarkets.com  Business Wire Worldwide Whole Genome and Exome Sequencing Industry to 2026 - Featuring 10x Genomics, Abbott Diagnostics and Agilent Among Others  PRNewswire Clinical Diagnostics Market is Going to Boom with Siemens Healthcare, Sonic Healthcare, Charles River Laboratories ? UK Parents Lounge  UK Parents Lounge Genzyme Ireland sees 50% growth in profits to ?65.2m  The Irish Times Aesthetic Fillers Market is Expected to Reach USD 4.6 Billion by 2027 - AllTheResearch  GlobeNewswire Harvard Business School's Baker Library Announces New Collection: John Hawkins Research Interviews about Henri Termeer, Longtime Chairman, CEO, and President of Genzyme Corporation - News  Harvard Business School Joseph Arron marches to the beat of his own drum at 23andMe; Ex-Voyager CFO joins Sek Kathiresan at Verve Therapeutics  Endpoints News Vericel Expands Executive Leadership Team and Announces Appointment of Patrick Fowler as Senior Vice President, Corporate Development and Strategy  Yahoo Finance ReForm Biologics Announces Corporate Reorganization  Business Wire Gaucher Disease Treatment Market 2021 ? 2028 | Industry In-depth Analysis By Players Genzyme Corporation, Pfizer, Inc., Shire Human Genetics Therapies, Inc.  Medgadget The Petri Dish: Former Genzyme CFO joins biologics startup - Boston Business Journal  Boston Business Journal FDA Approves New Treatment for Pompe Disease | FDA  FDA.gov Sanofi-aventis to Acquire Genzyme for $74.00 in Cash per Share Plus Contingent Value Right  FierceBiotech Sanofi is betting big on mRNA vaccines after Moderna, Pfizer see success with COVID-19 shots  The Boston Globe Sanofi approaches Genzyme for acquisition: sources  Reuters Abeona Therapeutics Appoints Gene Therapy Quality Leader Jon Voss as Vice President, Head of Quality  Yahoo Finance Sanofi-aventis buys Genzyme for $20 billion - Feb. 16, 2011  CNNMoney Movers & Shakers, Sept. 17 | BioSpace  BioSpace Sanofi announces settlement agreement related to Contingent Value Rights (CVRs) Litigation  GlobeNewswire Potential SRT for Neuronopathic Gaucher Shows Efficacy in Early Study  Gaucher Disease News Sanofi-Aventis Completes Acquisition of Genzyme Corporation  PR Newswire M&A Objection Lawsuits and Claims for Inadequate Consideration: A ?Bumpy? Road for D&O Insurers  JD Supra Gemini Therapeutics Announces Appointment of Georges Gemayel, Ph.D. as Chair of Board of Directors  Business Wire Magenta Therapeutics Appoints Thomas Beetham as Chief Legal Officer  Yahoo Finance Henri A. Termeer Square Officially Dedicated in Cambridge  Business Wire Titan Medical Expands Senior Leadership Team  Business Wire VBI Vaccines Appoints Linda Bain to Board of Directors  Business Wire Exclusive: Relational analysis puts Genzyme value at $93/shr  Reuters
For more news about GENZYME CORPORATI click here:
GENZYME CORPORATI News 

Search the Internet:

Website Width:
Bookmark and Share

 Background image:

Copyright@2010-2021 - TR4DER.com, all rights reserved.
Investment Forum Stock Quotes Investment News Investment Chat Disclaimer Webmaster Resources